Andrej Alendar
Impact in
-
- Cancer Mechanisms and Therapy
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Genomics and Chromatin Dynamics 2
- Cancer-related gene regulation 2
- Chromatin Remodeling and Cancer 2
- Kruppel-like factors research 1
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Anton Berns (3 shared papers)Martijn C. Nawijn (1 shared paper)Tony Kouzarides (3 shared papers)Andrew J. Bannister (2 shared papers)Luca Pandolfini (2 shared papers)Samuel C. Robson (1 shared paper)Shankar Balasubramanian (1 shared paper)Rossella Brandi (1 shared paper)
- Journals
- Molecular Cell (1 paper)FEBS Letters (1 paper)Nature reviews. Cancer (1 paper)PLoS ONE (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- NetherlandsUnited KingdomItaly
In The Last Decade
Andrej Alendar
9 papers receiving 865 citations
Andrej Alendar's Hit Papers
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 322
- Cancer Research 229
- Molecular Biology 583
- Oncology 172
- Hematology 47
Countries citing papers authored by Andrej Alendar
This map shows the geographic impact of Andrej Alendar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Alendar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Alendar more than expected).
Fields of papers citing papers by Andrej Alendar
This network shows the impact of papers produced by Andrej Alendar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Alendar. The network helps show where Andrej Alendar may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrej Alendar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 381 | |
| 2 | METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation Hit paper breakdown → | 2019 | 363 |
| 3 | 2014 | 39 | |
| 4 | 2018 | 35 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2003 | 5 |
About Andrej Alendar
Andrej Alendar is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Oncology and Cellular and Molecular Neuroscience, having authored 9 papers that have together received 875 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers), Genomics and Chromatin Dynamics (2 papers), Cancer Mechanisms and Therapy (2 papers), Cancer-related gene regulation (2 papers), Chromatin Remodeling and Cancer (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (322 citations), Cancer Research (229 citations), Molecular Biology (583 citations), Oncology (172 citations) and Hematology (47 citations). Andrej Alendar has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include Anton Berns, Martijn C. Nawijn, Tony Kouzarides, Andrew J. Bannister, Luca Pandolfini, Samuel C. Robson, Shankar Balasubramanian, Rossella Brandi, Pierre Murat and Valentina Migliori. Their work appears in journals such as Molecular Cell, FEBS Letters, Nature reviews. Cancer, PLoS ONE and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.